MIT Student Project Develops FDA-Cleared Device for Essential Tremor
A device initially conceived by MIT students for Parkinson's disease has received FDA clearance to assist adults with essential tremor. The startup, Encora Therapeutics, evolved from an MIT product-design class, with clinical trials showing 78% of patients benefited. This marks a significant step in making a new non-invasive treatment option available.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.